Bridgebio Oncology Therapeutics, Inc. (BBOT)
7.31
-0.47
(-6.04%)
USD |
NASDAQ |
Jun 09, 16:00
7.31
0.00 (0.00%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics SG&A Expense (Quarterly) : 6.377M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Erasca, Inc. | 10.65M |
| Bicara Therapeutics, Inc. | 12.74M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |
| Sangamo Therapeutics, Inc. | 6.818M |